Funded Tech Companies
Lysosomal Therapeutics
Headquartered in Cambridge, Lysosomal Therapeutics has funding from Lilly Ventures, Sanofi-Genzyme BioVentures and Roche Venture Fund.
Company Overview
Company Name
Lysosomal Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
19 Blackstone St.
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Company Background Information
Overview
LTI's unique approach to discovering new drugs for neurodegenerative diseases is based on research performed in the lab of Dr. Dimitri Krainc, one of the company's founders, at Massachusetts General Hospital (MGH), a founding member of Partners HealthCare and an affiliate of Harvard Medical School.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
2/3/2015
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kees Been
Chief Financial Officer
Daniel Geffken
Chief Marketing Officer
Dana Hilt
Chief Scientific Officer
Peter Lansbury
Vice President
Valerie Cullen
VP - Bus. Development
Darren Braccia
VP - Bus. Development
Renato Skerlj
VP - Bus. Development
Andrew Sonderfan
Company Investors
- Lilly Ventures (Steven Hall)
- Sanofi-Genzyme BioVentures (Bernard Davitian)
- Roche Venture Fund (Carole Nuechterlein)
- Atlas Venture (Bruce Booth)
- Orion Equity Partners
- Hatteras Venture Partners (Clay Thorp)
- Partners Innovation Fund (Reza Halse)
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs